![]()  | - SMTL ID
 - 3zrc.1
 - Ligands
 - (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE
 - Polypeptides
 - TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
 - Oligo-state
 - hetero-1-1-1-mer
 
  | 
![]()  | - SMTL ID
 - 3zrc.2
 - Ligands
 - (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE
 - Polypeptides
 - TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
 - Oligo-state
 - hetero-1-1-1-mer
 
  | 
![]()  | - SMTL ID
 - 3zrc.3
 - Ligands
 - (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE
 - Polypeptides
 - TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
 - Oligo-state
 - hetero-1-1-1-mer
 
  | 
![]()  | - SMTL ID
 - 3zrc.4
 - Ligands
 - (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE
 - Polypeptides
 - TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
 - Oligo-state
 - hetero-1-1-1-mer
 
  |